Abbvie Earnings Estimate

ABBV
 Stock
  

USD 142.19  0.90  0.64%   

Many public companies, such as Abbvie, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing Abbvie's earnings estimates, investors can diagnose different trends across Abbvie's analyst sentiment over time as well as compare current estimates against different timeframes.
Abbvie is projected to generate 12.68 in earnings per share on the 31st of December 2021. Abbvie earnings estimates module stress-tests analyst consensus about projected Abbvie Inc EPS (Earning Per Share) to derive its highest and lowest estimates based on its historical volatility. Please continue to Trending Equities.
  
Gross Profit is likely to drop to about 32.8 B in 2022. Profit Margin is likely to drop to 0.19 in 2022

Abbvie Earnings Estimation Breakdown

Calculation of earning per share of Abbvie Inc is based on official Zacks consensus of 5 analysts regarding Abbvie future annual earnings. Given the historical accuracy of 97.73%, the future earnings per share of Abbvie is estimated to be 12.68 with the lowest and highest values of 12.64 and 12.75, respectively. Please note that this consensus of annual earnings estimates for Abbvie Inc is an estimate of EPS before non-recurring items and including employee stock options expenses
  Current EPS 4.2
12.64
Lowest
Expected EPS 12.68
12.75
Highest

Abbvie Earnings Projection Consensus

Suppose the current estimates of Abbvie's value are higher than the current market price of the Abbvie stock. In this case, investors may conclude that Abbvie is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Abbvie's stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyCurrent EPSEPS Estimate for 31st of December 2021

5

97.73%

4.2

12.68

Abbvie Earnings History

Earnings estimate consensus by Abbvie Inc analysts from Wall Street is used by the market to judge Abbvie's stock performance. The investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only Abbvie's upcoming profit reports and earnings-per-share forecasts but also compare them to our different valuation methods.

Abbvie Quarterly Earnings Before Interest Taxes and Depreciation Amortization EBITDA

3.76 Billion

Abbvie Accumulated Retained Earnings Deficit are fairly stable at the moment as compared to the past year. Abbvie reported Accumulated Retained Earnings Deficit of 3.13 Billion in 2021. Price to Earnings Ratio is likely to climb to 22.53 in 2022, whereas Earnings per Basic Share are likely to drop 5.38 in 2022. Abbvie Weighted Average Shares is fairly stable at the moment as compared to the past year. Abbvie reported Weighted Average Shares of 1.77 Billion in 2021. Weighted Average Shares Diluted is likely to climb to about 1.9 B in 2022, whereas Issuance Purchase of Equity Shares is likely to drop (744.5 M) in 2022.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Abbvie's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Abbvie in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
140.92142.26143.60
Details
Intrinsic
Valuation
LowReal ValueHigh
142.17143.51144.85
Details
Naive
Forecast
LowNext ValueHigh
146.35147.69149.03
Details
13 Analysts
Consensus
LowTarget PriceHigh
118.00143.42172.00
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Abbvie. Your research has to be compared to or analyzed against Abbvie's peers to derive any actionable benefits. When done correctly, Abbvie's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Abbvie Inc.
Note that many institutional investors and large investment bankers can move markets due to the volume of Abbvie assets they manage. They also follow analysts to some degree and often drive overall investor sentiments towards Abbvie. With so many stockholders watching consensus numbers, the difference between actual and projected earnings is one of the most critical factors driving Abbvie stock price in the short term.

Abbvie Earnings per Share Projection vs Actual

Actual Earning per Share of Abbvie refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Abbvie Inc predict the company's earnings will be in the future. The higher the earnings per share of Abbvie, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

Abbvie Estimated Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as Abbvie, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Abbvie should always be considered in relation to other companies to make a more educated investment decision.

Abbvie Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact Abbvie's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2022-07-29
2022-06-303.313.370.06
2022-04-29
2022-03-313.143.160.02
2022-02-02
2021-12-313.293.310.02
2021-10-29
2021-09-303.223.330.11
2021-07-30
2021-06-303.093.110.02
2021-04-30
2021-03-312.832.950.12
2021-02-03
2020-12-312.852.920.07
2020-10-30
2020-09-302.772.830.06
2020-07-31
2020-06-302.192.340.15
2020-05-01
2020-03-312.252.420.17
2020-02-07
2019-12-312.192.210.02
2019-11-01
2019-09-302.32.330.03
2019-07-26
2019-06-302.212.260.05
2019-04-25
2019-03-312.052.140.09
2019-01-25
2018-12-311.941.9-0.04
2018-11-02
2018-09-302.022.140.12
2018-07-27
2018-06-301.9720.03
2018-04-26
2018-03-311.791.870.08
2018-01-26
2017-12-311.441.480.04
2017-10-27
2017-09-301.391.410.02
2017-07-28
2017-06-301.41.420.02
2017-04-27
2017-03-311.261.280.02
2017-01-27
2016-12-311.21.20
2016-10-28
2016-09-301.21.210.01
2016-07-29
2016-06-301.21.260.06
2016-04-28
2016-03-311.131.150.02
2016-01-29
2015-12-311.121.130.01
2015-10-30
2015-09-301.081.130.05
2015-07-24
2015-06-301.061.080.02
2015-04-23
2015-03-310.850.940.0910 
2015-01-30
2014-12-310.860.890.03
2014-10-31
2014-09-300.770.890.1215 
2014-07-25
2014-06-300.760.820.06
2014-04-25
2014-03-310.680.710.03
2014-01-31
2013-12-310.820.820
2013-10-25
2013-09-300.780.820.04
2013-07-26
2013-06-300.790.820.03
2013-04-26
2013-03-310.670.680.01
2013-01-23
2012-12-310.990.9761-0.0139

About Abbvie Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Abbvie earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Abbvie estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Abbvie fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.

Abbvie Investors Sentiment

The influence of Abbvie's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Abbvie. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.
Investor biases related to Abbvie's public news can be used to forecast risks associated with investment in Abbvie. The trend in average sentiment can be used to explain how an investor holding Abbvie can time the market purely based on public headlines and social activities around Abbvie Inc. Please note that most equiteis that are difficult to arbitrage are affected by market sentiment the most.
Abbvie's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Abbvie's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Abbvie's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Abbvie.

Abbvie Implied Volatility

    
  27.62  
Abbvie's implied volatility exposes the market's sentiment of Abbvie Inc stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Abbvie's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Abbvie stock will not fluctuate a lot when Abbvie's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Abbvie in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Abbvie's short interest history, or implied volatility extrapolated from Abbvie options trading.

Pair Trading with Abbvie

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Abbvie position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abbvie will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Abbvie could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Abbvie when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Abbvie - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Abbvie Inc to buy it.
The correlation of Abbvie is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Abbvie moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Abbvie Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Abbvie can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Please continue to Trending Equities. Note that the Abbvie Inc information on this page should be used as a complementary analysis to other Abbvie's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Complementary Tools for Abbvie Stock analysis

When running Abbvie Inc price analysis, check to measure Abbvie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbvie is operating at the current time. Most of Abbvie's value examination focuses on studying past and present price action to predict the probability of Abbvie's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Abbvie's price. Additionally, you may evaluate how the addition of Abbvie to your portfolios can decrease your overall portfolio volatility.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Is Abbvie's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abbvie. If investors know Abbvie will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abbvie listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
0.21
Market Capitalization
251.5 B
Quarterly Revenue Growth YOY
0.045
Return On Assets
0.0814
Return On Equity
0.93
The market value of Abbvie Inc is measured differently than its book value, which is the value of Abbvie that is recorded on the company's balance sheet. Investors also form their own opinion of Abbvie's value that differs from its market value or its book value, called intrinsic value, which is Abbvie's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abbvie's market value can be influenced by many factors that don't directly affect Abbvie's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Abbvie's value and its price as these two are different measures arrived at by different means. Investors typically determine Abbvie value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abbvie's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.